close
close

To watch European Penny shares in March 2025

Since the Pan-European Stoxx Europe 600 Index continues its upward railway and marks its longest weekly profits since August 2012, investors are carefully optimistic despite mixed economic signals such as Germany and France. For those who are willing to explore beyond the established market leaders, Penny shares – often among them smaller or newer companies – show a relevant investment area. Although these shares are historically considered speculative, they can offer unique growth opportunities if they are supported by strong financial data and resistance to broader market unconcursions.

name

Stock price

Market capitalization

Financial health rating

Angler Gaming (NGM: Angl)

Sec3.92

SEK293.94m

★★★★earch

Transferator (NGM: Tran A)

SEK2.29

SEK221.95m

★★★★earch

Deceuninck (Enxtbr: Decb)

€ 2.135

295.47 m

★★★★earch

Hifab Group (OM: HIFA B)

SEK3.84

SEK233.62m

★★★★earch

Netgeem (enxterpa: alntg)

0.978 €

32.75 m

★★★★earch

High (enxterpa: hco)

€ 2.69

52.84 m

★★★★earch

IMD International Medical Devices (Bit: IMD)

€ 1.43

24.77 m

★★★★★ ☆

Bredband2 I Scandinavia (OM: BRE2)

SEK2.065

Sek1.98b

★★★★ ☆itch

Arcure (Enxtpa: Alcur)

4.81 €

27.81 m

★★★★ ☆itch

IMS (WSE: IMS)

PLN3.65

Pln123.71m

★★★★ ☆itch

Click here to display the full list of 432 shares from our European Penny Stocks Screener.

Let us immerse yourself in some first -class options from the screen.

Simply Wall ST Financial Health Rating: ★★★★★ ☆

Overview: Forfarmers NV acts as a provider of feed solutions for conventional and organic cattle breeding construction in several countries, including the Netherlands, Great Britain, Germany, Poland and Belgium, with a market capitalization of € 376.89 million.

Operations: The company generates sales of € 2.75 billion from its food processing segment.

Market capitalization: 376.89 m

Forfarmers NV recently became profitable and reported a net result of € 31.4 million for 2024 compared to a loss in the previous year. Despite an annual decline in profit by 8.5% over five years, financial health is supported by short -term assets that exceed the liabilities and satisfactory debt insurance with the operational cash flow at 65.3%. The shares are significantly below their estimated atmosphere and offer potential advantages if the market conditions improve. The challenges, however, include an unstable dividend track record and a relatively inexperienced management team with an average term of 1.5 years that can affect the strategic execution.

Enxtam: FFARM sales and output traces as on March 2025

Simply Wall ST Financial Health Rating: ★★★★earch